1. Home
  2. ASTL vs VNDA Comparison

ASTL vs VNDA Comparison

Compare ASTL & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Algoma Steel Group Inc.

ASTL

Algoma Steel Group Inc.

N/A

Current Price

$3.83

Market Cap

467.0M

Sector

Industrials

ML Signal

N/A

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

N/A

Current Price

$9.34

Market Cap

474.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ASTL
VNDA
Founded
1902
2002
Country
Canada
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
467.0M
474.0M
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
ASTL
VNDA
Price
$3.83
$9.34
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$14.90
AVG Volume (30 Days)
1.2M
3.7M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
2.31%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$216,105,000.00
Revenue This Year
N/A
$21.50
Revenue Next Year
$33.17
$38.67
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.72
52 Week Low
$3.02
$3.81
52 Week High
$7.25
$9.91

Technical Indicators

Market Signals
Indicator
ASTL
VNDA
Relative Strength Index (RSI) 35.32 63.29
Support Level $3.54 $7.39
Resistance Level $4.77 $9.60
Average True Range (ATR) 0.27 0.61
MACD -0.09 0.19
Stochastic Oscillator 2.11 75.38

Price Performance

Historical Comparison
ASTL
VNDA

About ASTL Algoma Steel Group Inc.

Algoma Steel Group Inc is a fully integrated steel producer of hot and cold rolled steel products, including coiled sheet and plate, strategically located. The firm operates in a single segment of basic steel production including sheets, plates, slabs, and freights. The company's revenue is generated from contracts to produce, ship, and deliver steel products Geographically it serves Canada, the United States, and the rest of the world, whilst driving key revenue from domestic sales. The company generates the majority of its revenue from the sale of Steel sheets and strips.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: